Reference
Ma J, et al. Improved efficacy and safety of low-dose oxaliplatin/pegylated liposomal doxorubicin/S-1 regimen in advanced gastric cancer: a cohort study. Annals of Palliative Medicine 10: 12821-12830, No. 12, Dec 2021. Available from: URL: http://doi.org/10.21037/apm-21-3584
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1934, 42 (2022). https://doi.org/10.1007/s40278-022-28423-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-28423-1